 | This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (December 2018) |
 | |
| Company type | Public |
|---|---|
| |
| Founded | 1999 |
| Headquarters | San Diego, California, U.S. |
Key people | Kevin Sayer (chairman, president & CEO) |
| Products | Medical devices |
| Revenue |  US$4.03 billion (2024) |
| US$600 million (2024) | |
| US$576 million (2024) | |
| Total assets | US$6.48 billion (2024) |
| Total equity | US$2.10 billion (2024) |
Number of employees | 10,300 (2024) |
| Website | dexcom |
| Footnotes / references [1] | |
DexCom, Inc.[2] is an American heathcare company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland.
- ^ "2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. February 18, 2025.
- ^ "DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People with Diabetes" (Press release). 26 April 2022.